Showing 1 posts of 1 posts found.
The FDA has approved Merck’s eye solution Zioptan to treat a common eye condition. Zioptan (tafluprost ophthalmic solution) can now …
Product value to pathway impact: What the CVD Modern Service Framework means for pharma
MHRA awards Innovation Passports to liver cancer and dementia medicines
Scottish NHS hospital adopts light-activated therapy to reduce surgical infections
Manchester launches nurse-led clinic to improve kidney transplant outcomes
Androlabs and Majorelle expand testosterone therapy into France